A Clinical Trial to Evaluate Safety and Efficacy of a Renal Denervation System in Treatment of Hypertension
Status:
Unknown status
Trial end date:
2019-08-31
Target enrollment:
Participant gender:
Summary
This is a multicentre clinical trial to evaluate safety and efficacy of renal denervation
system in treatment of hypertension. Hypertensive patients who meet enrollment criteria will
be randomized into treatment group who will receive standardized drugs and renal denervation
treatments, or control group who will receive standardized drugs and a sham procedure (renal
artery angiography only without denervation). The patients will be monitored for blood
pressure changes and any adverse events for 6 months. The safety and efficacy of the device
will be evaluated by comparing blood pressure levels and adverse event episodes between the
two groups.